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There is increasing emphasis on screening, brief intervention, and referral to treatment (SBIRT) for unhealthy alcohol
use in the general hospital, as highlighted by new Joint Commission recommendations on SBIRT. However, the
evidence supporting this approach is not as robust relative to primary care settings. This review is targeted to
hospital-based clinicians and administrators who are responsible for generally ensuring the provision of high quality
care to patients presenting with a myriad of conditions, one of which is unhealthy alcohol use. The review
summarizes the major issues involved in caring for patients with unhealthy alcohol use in the general hospital
setting, including prevalence, detection, assessment of severity, reduction in drinking with brief intervention,
common acute management scenarios for heavy drinkers, and discharge planning. The review concludes with
consideration of Joint Commission recommendations on SBIRT for unhealthy alcohol use, integration of these
recommendations into hospital work flows, and directions for future research.
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Alcohol-related problems constitute a tremendous eco-
nomic and health cost in many countries throughout the
world [1,2]. Screening, brief intervention, and referral to
treatment (SBIRT) has become one of the major tools
used to combat these problems, and is widely
recommended for use in primary care by governments
and expert panels [3,4]. Recently, the Joint Commission
on Accreditation for Health Care Organizations
(JCAHO), the major accrediting body for hospitals in
the US, has advanced SBIRT as a quality indicator for
general hospital care [5]. There is no doubt that alcohol
problems are a critical issue in hospital care, but there
are concerns that the evidence base does not yet justify
widespread SBIRT in this setting [6]. This review will
consider the nature of unhealthy alcohol use in the gen-
eral hospital, review means for detecting unhealthy use
and categorizing severity, consider the evidence on the
effectiveness of SBIRT in the hospital setting, briefly re-
view acute treatment issues, and discuss factors affecting
the implementation of SBIRT into general hospital
workflows. The goal is to provide an overview of the* Correspondence: ss243@buffalo.edu
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distribution, and reproduction in any mediumfield that will aid hospital-based clinicians and adminis-
trators in their consideration of policies and procedures
that will yield the highest quality care for their patients.
In this regard, the impact of detecting and treating un-
healthy alcohol use is one of many important health care
issues that must be evaluated.Unhealthy alcohol use in the hospital
Unhealthy alcohol use is an umbrella term
encompassing any pattern of alcohol use that increases
risk for or causes physical problems [7]. At the lower
end of severity, unhealthy use is often operationalized as
drinking in excess of health-related guidelines. In the
US, the National Institute on Alcohol Abuse and Alco-
holism defines this as more than one drink daily, more
than 7 drinks weekly, or exceeding 3 drinks on a given
day for women and for men ≥ 65, and more than two
drinks daily, more than 14 drinks weekly, or exceeding 4
drinks on a given day for men < 65 [8]. Pertinent to
these guidelines, a standard drink is defined as a volume
of beverage containing 14 grams of alcohol. This corre-
sponds to a 12-oz (355 ml) beer containing 5% alcohol
by volume, 5 oz. (148 ml) of wine containing 12% alco-
hol, or 1.5 oz. (44 ml) of spirits containing 40% alcohol.
While modestly exceeding these limits in a sustainedCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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harms, this pattern is variably associated with increased
morbidity in the long term relative to lighter drinking
[9-11]. At the higher end of severity is the daily or fre-
quent consumption of large amounts of alcohol, with
sharply increased risks for alcohol dependence, cirrhosis,
upper airway and gastrointestinal tract cancers, demen-
tia, and other highly morbid conditions.
The prevalence of unhealthy use among hospital inpa-
tients will depend on characteristics of hospitals and the
populations they serve [12]. However, a systematic re-
view of screening studies suggested an overall average of
about 17% will self-report unhealthy use [13], with a 3-
fold increase in men relative to women. This summary
estimate is less than the prevalence in the general adult
population [8]. However, because unhealthy alcohol use
is most common in younger males, unhealthy use is felt
to increase the risk for hospitalization after accounting
for age and gender [14]. Among general hospital patients
who do consume alcohol, regardless of the presence of
unhealthy use, about one-quarter will have an alcohol
use disorder, which is much higher relative to current
drinkers in the general population [15-17]. In addition
to their physical health problems, relative to the non-
hospitalized alcohol dependent population, hospitalized
alcohol-dependent individuals have a higher prevalence
of polysubstance use and mental health comorbidities
[18]. Thus, while inpatient clinicians provide care for pa-
tients representing the broad spectrum of unhealthy al-
cohol use, there is a particularly high prevalence of
complex alcohol dependent patients. Because brief inter-
vention is most effective in patients with less severe un-
healthy alcohol use, this has profound implications for
the effectiveness of hospital-based SBIRT. Of note, des-
pite these increased health risks, the evidence on severe
unhealthy alcohol use and early hospital readmission is
mixed [19,20], and may depend on concurrent abuse of
other drugs.
Detecting and categorizing the severity of unhealthy
alcohol use
The process of detecting and categorizing the severity of
unhealthy alcohol use focuses on two aspects of alcohol
involvement. Firstly, the amount of alcohol consumed
must be quantified, and this will determine the presence
or absence of unhealthy use. Secondly, alcohol-related
consequences should be assessed to determine the pres-
ence of an alcohol use disorder.
Assessment for unhealthy alcohol use
Alcohol use is often recorded in a hospital admission
history & physical by the frequency with which a certain
amount of alcohol is consumed. With this method, alco-
hol use should be estimated in an unambiguous mannerusing the definition of a standard drink, and aids are avail-
able to assist clinicians and their patients in estimating al-
cohol consumption [8]. Rather than non-standardized
questioning to characterize alcohol use, a number of short
instruments have been evaluated [21], and their brevity
should facilitate standardized screening in the hospital.
Some of these tools are listed in Table 1, including the
AUDIT-C [22-24], quantity-frequency items [24,25] , and
heavy drinking day question [26,27], any of which should
target past-year drinking. The estimates shown in the table
were derived from primary care samples [24,27], and could
differ to some extent in hospitalized patients. None of the
instruments are perfectly specific, and positive results
should trigger additional inquiry to characterize drinking
and confirm unhealthy alcohol use.
An added complexity of assessing for unhealthy alcohol
use in hospitalized patients is illness severity, which may
prohibit obtaining information directly from the patient.
In such circumstances the presence of unhealthy alcohol
use can often be estimated from past medical records or
surrogate reporters. When alcohol-related disease is
suspected blood alcohol levels can be helpful if heavy
drinking occurred in the past 8 to 12 hours (an average
elimination is roughly one drink per hour). Gamma-
glutamyltransferase also has some utility, but will be less
specific for chronic heavy drinking in medical settings
[28]. Carbohydrate-deficient transferrin, another bio-
marker for chronic heavy drinking, has been shown to
predict adverse perioperative events [29], but is limited by
modest sensitivity. In addition, results may not be available
for several days, limiting use for decision-making in the
hospital. Newer alcohol consumption biomarkers that re-
quire ethanol for their synthesis (e.g., urine ethyl glucuro-
nide [30], blood phosphatidylethanol [31]) are a research
focus and clearly have potential clinical utility [32-39]). In
general however, pending the development of cost-
effective, widely-available assays at the point of care, use of
these newer biomarkers in risk-stratifying for alcohol
problems at the time of hospitalization is not yet feasible
in most locations.
Assessment for alcohol use disorders in patients with
unhealthy use
In patients with unhealthy alcohol use, characterization
of severity requires an assessment of recent alcohol-
related problems, which will often satisfy the criteria for
an alcohol use disorder in hospitalized patients [16]. A
number of screening instruments for alcohol use dis-
order have been developed, and some are listed in
Table 2 [21,40].
Importantly, as for any ordinal screening instruments,
different cutoff scores will result in a tradeoff between
sensitivity and specificity. In addition, relatively low cut-
off scores on an instrument that assesses both the
Table 1 Selected findings on brief screening tools for unhealthy alcohol use
Screening tool Positive result Sensitivity Specificity Study Populations
(95% CI) (95% CI)
AUDIT-C ≥ 4 (men) 86 (80-92) men 89 (85-93) men Primary care [24]
(3 items)* ≥ 3 (women) 73 (66-79) women 91 (89-93) women
Quantity-Frequency Exceeding recommended 88 (83-94) men 84 (80-89) men Primary care [24]
(3 items)* drinking limits 68 (61-75) women 91 (89-93) women
Heavy-drinking day Any heavy days
(≥ 4 drinks women, ≥ 5 drinks men)
83 (71-90) men 72 (61-81) men Primary care [27]
past year (1 item) 81 (64-91) women 84 (76-89) women
*The AUDIT-C and quantity-frequency items were identical, with different interpretations of a positive result.
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can be used to screen for unhealthy alcohol use and
alcohol use disorders (e.g., as with the AUDIT [41]). Ul-
timately however, a diagnosis of an alcohol use disorder
should be based on an assessment of established criteria.
The American Psychiatric Association (Diagnostic and
Statistical Manual/DSM) and World Health Organization
(International Classification of Disease/ICD) have developed
criteria for a diagnosis of current alcohol dependence that
substantially overlap, and require the presence of at least 3
of the diagnostic criteria during the past 12 months (or co-
occurring more distantly for alcohol dependence in remis-
sion). The current DSM-IV criteria for dependence and
abuse are listed in Table 3. Importantly, due to evidence that
alcohol problems exist on a continuum rather than sharply
defined categories, the upcoming revision of the DSM in
2013 (DSM-V) will controversially do away with the terms
“abuse” and “dependence”, and will have only “alcohol use
disorder” [42,43]. Individuals satisfying 2 or 3 of the 11 cri-
teria will be classified as having “moderate” alcohol use dis-
order, and those meeting 4 or more criteria will be classified
with “severe” alcohol use disorder. This DSM-V reclassifica-
tion may cause some initial confusion, but the concept of a
single disorder that varies in severity will likely be a welcome
change for many hospital-based clinicians.
Treatment for unhealthy alcohol use
Treatment for non-dependent unhealthy alcohol use
After initial screening and clinical assessment, patients
with unhealthy alcohol use will have been categorized asTable 2 Selected findings on brief screening tools for alcohol
Instrument Positive result Sensitivity
AUDIT ≥ 8 Range
(10 items)* 61 to 96
CAGE ≥ 2 Range
(4 items) 77 to 94
RAPS4 ≥ 1 93
(4 items)
*AUDIT includes the AUDIT-C and can be used to screen for unhealthy alcohol use.
screen for unhealthy alcohol use and alcohol use disorders.having or not having an alcohol use disorder. In the latter,
the clinical effort should be aimed at drinking reduction
to levels that are unlikely to contribute to health problems.
To accomplish this, the evidence, while mixed, generally
favors a modest effect of brief interventions during
hospitalization. A meta-analysis [44] of 4 randomized con-
trolled trials (one in trauma patients did not exclude de-
pendence, two excluded dependence, and one excluded
patients with alcohol-related physical problems) con-
cluded that brief intervention for unhealthy drinkers
reduced alcohol consumption by an average of approxi-
mately 5 drinks/week 6 months post-intervention. Exclu-
sion of the trauma-based trial due to unblinded outcome
assessment reduced the magnitude and statistical signifi-
cance of this estimate. Reported alcohol use at one year
was synthesized for 4 other studies (3 with variable exclu-
sion of patients with alcohol use disorders) and, although
there was roughly a 2 drink per week reduction in the
intervention groups, this was not statistically significant
relative to controls. Importantly, while the evidence base
for outcomes other than alcohol use is relatively under-
developed, this meta-analysis found evidence that brief
intervention was associated with decreased mortality at
one year. In addition, a US study of trauma patients
reported a 47% reduction in recurrent trauma over the 3
years following receipt of brief intervention [45].
Overall, the evidence tends to favor brief intervention
for hospitalized patients with less severe unhealthy alco-
hol use. A number of different strategies have been stu-
died, but brief intervention in the hospital shoulduse disorders
Specificity Study populations
Range Systematic review of primary care studies [21]
85 to 96
Range Systematic review of primary care studies [21]
79 to 97
87 Emergency department patients [40]
Similarly, screens in Table 1 can be combined with screens in Table 2 to jointly
Table 3 American Psychiatric Association criteria for alcohol use disorders
DSM-IV Alcohol dependence DSM-IV Alcohol abuse DSM-V Alcohol use disorder
(≥ 3 of the following) (≥ 1 of the following) (≥ 2 of the following)
• Tolerance Continued drinking despite…. • Tolerance
• Withdrawal • Withdrawal
• Repeatedly exceeding intended limits • Increased risk for
physical harm
• Repeatedly exceeding intended limits
• Spending a lot of time drinking or
recovering from alcohol effects
• Trouble in important
relationships
• Spending a lot of time drinking or
recovering from alcohol effects
• Failed attempts to cut down or abstain • Failure to perform important
roles
• Failed attempts to cut down or abstain
• Continued drinking despite physical or psychological
problems
• Legal problems* • Continued drinking despite physical or psychological
problems
• Spending less time on important activities
due to drinking
• Spending less time on important
activities due to drinking
• Increased risk for physical harm
• Trouble in important relationships
• Failure to perform important roles
• Craving for alcohol*
*“Legal problems” will be dropped as an alcohol use disorder criterion, and “craving” will be added.
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ing associations with conditions the patient may have such
as hypertension), advice to reduce consumption to safer
levels, an explanation of why these limits are recommen-
ded, a non-confrontational inquiry to determine a patient’s
interest in reducing their drinking, and determination of a
plan to achieve drinking goals [46]. This can be delivered
by a variety of health care personnel [44,47], which can
lower the cost of brief intervention.
Acute Treatment for alcohol use disorders (typically
accompanied by frequent heavy drinking)
The potential for acute complications renders the detec-
tion of alcohol use disorders and associated heavy drink-
ing particularly important at the time of hospitalization.
A number of informative reviews are available for guid-
ing care [7,48-50], and only a brief summary is provided
here (Table 4). In patients with prior severe withdrawal
or unstable medical disease, clinicians may wish to insti-
tute preventive measures for acute alcohol withdrawal
with fixed dose benzodiazepines (e.g., chlordiazepoxide
50 mg every 6 hours for 24 hours followed by 25 mg
every 6 hours for 48 hours) [48]. Patients must still be
monitored for over-sedation or inadequate dosing. Ac-
tive withdrawal can be managed with symptom-triggered
or scheduled benzodiazepine dosing, with the former
resulting in decreased benzodiazepine use and shorter
treatment duration [51]. Several potential regimens are
listed in Table 5 [49,51-53], and use of a shorter-acting
benzodiazepine (e.g., lorazepam) will require a taper to
prevent recurrent symptoms. Monitoring and dosingmust be guided by a validated symptom scale such as the
Clinical Institute Withdrawal Assessment for Alcohol-
revised (CIWA-Ar) or somewhat shorter CIWA-AD
[54-56] administered by trained personnel. Inappropriate
selection of patients for symptom-triggered therapy has
been reported, with the major reasons being inability to
communicate (and thus assess all withdrawal symptoms),
lack of heavy drinking in the days preceding hospita-
lization, and other causes of delirium [57]. Thus an accur-
ate history is required and other causes of delirium must
always be considered. For example, chronic heavy drinking
suppresses the immune system [58,59], and clinicians
must remain vigilant for infections such as pneumonia or
sepsis. Other causes of delirium (e.g., hypoxia, stroke, ef-
fects of drugs other than alcohol, etc.) may also need to be
ruled out depending on the clinical circumstances.
Initial treatment of severe withdrawal may require intra-
venous benzodiazepines (e.g., 2 to 4 mg of lorazepam or 5
to 10 mg of diazepam) and additional dosing as needed to
control symptoms. Usually benzodiazepines alone are suf-
ficient, and a strong evidence base supports their use [60].
The rare patient with severe withdrawal who fails benzodi-
azepine treatment will require intensive monitoring and
treatment with barbiturates or propofol [49]. Phenobar-
bital is most frequently used in this circumstance, with 30
mg having roughly equivalent effects on withdrawal symp-
toms as 2 mg lorazepam, 25 mg chlordiazepoxide, or 10
mg diazepam [53]. Some centers with expertise in alcohol
withdrawal treatment use anticonvulsants (e.g., carba-
mazepine, gabapentin) as a primary prophylaxis or treat-
ment rather than benzodiazepines, but the evidence base
Table 4 Immediate issues in the care of chronic heavy drinkers admitted to the hospital
Clinical issue Treatment
Assess risk for nutritional deficiency • Thiamine supplementation.
• Possibly folate and multivitamin supplement.
Assess hydration status and electrolytes (risk for hypocalcemia and
hypomagnesemia with or without hypokalemia and
hypophosphatemia)
• IV or oral fluids.
• Oral or IV electrolyte replacement.
Risk for acute alcohol withdrawal • Close observation with validated instrument or prophylactic
benzodiazepine, particularly in those with previous withdrawals or history
of severe withdrawal (delirium tremens or seizure).
• Prophylaxis still requires close observation for over or under-sedation.
Active alcohol withdrawal • Symptom-triggered or scheduled benzodiazepine.
• Close observation with validated instrument with either symptom-
triggered or scheduled dosing.
• Alternate medication (e.g., phenobarbital) in rare event that
benzodiazepine is unsuccessful at controlling agitation.
• Possible beta blocker or clonidine for autonomic manifestations if
benzodiazepine alone is insufficient.
• Possible haloperidol if benzodiazepine alone is insufficient for delirium.
• Consider other causes of delirium.
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developed. In particular, anticonvulsants have not been
shown to reduce the incidence of alcohol withdrawal seiz-
ure or delirium tremens [61]. The use of intravenous alco-
hol infusions continues in some locations [62], mainly in
surgical specialties, due to some surgeons’ familiarity and
comfort with this treatment. This approach has been dis-
couraged due to potential toxicity (remembering that first-
pass metabolism can be substantial in chronic heavy
drinkers and is bypassed by this route), and evidence
shows that this approach is at best no more efficacious for
prophylaxis than benzodiazepines [63], and may have a
high failure rate [64,65].
Pre-operative assessment for patients with an alcohol use
disorder
Chronic heavy drinking (e.g., averaging at least 50 to 60
grams of alcohol per day or usually exceeding daily
limits) increases perioperative morbidity due to in-
creased risks for acute withdrawal syndrome, pneumoniaTable 5 Examples of symptom-triggered regimens for alcoho
Initial oral medication dose Frequency
Diazepam 10 to 20 mg if CIWA-Ar ≥ 8 to 10 Repeat same dose hourly unt
CIWA-Ar < 10
Chlordiazepoxide 50 mg if CIWA-Ar > 9 Repeat 50 mg hourly until CIW
Lorazepam 2 to 4 mg if CIWA-Ar ≥ 8 to 10 Repeat same dose hourly unt
CIWA-Ar < 10
*Fixed dose regimens generally consist of the same dose administered every 6 hou
Close monitoring is still critical as adjustments in dose, frequency, and length of tap
†Detailed descriptions are found in citations 48 and 53.and ARDS, wound infections, bleeding, myocardial dys-
function, and enhanced stress responses [59,66]. Thus
pre-operative detection should trigger efforts at detoxifi-
cation and achieving several weeks of abstinence before
elective procedures. For the more likely emergent proce-
dures in hospitalized patients, parenteral thiamine, elec-
trolyte replacement, and close monitoring and treatment
for post-operative withdrawal are important components
of care, and causes of delirium other than withdrawal
should be considered as they would be for patients who
are not heavy drinkers. Prevention of acute withdrawal
with benzodiazepines is an important consideration in
this population [67], and perioperative morphine may
reduce post-operative pneumonia by ameliorating neu-
roendocrine and immune imbalances induced by chronic
heavy drinking and peri-operative abstinence [68]. Much
of the perioperative management will naturally be di-
rected by the anesthesiologist and surgeon, and any con-
sulting physicians should make certain that these
providers are aware of the patient’s heavy drinking. Ofl withdrawal*†
Medication half-life
il Long half-life may provide smoother withdrawal, but
may accumulate in elderly or those with liver disease.
A-Ar < 10 Intermediate half-life may provide smoother withdrawal
than lorazepam.
il Short half-life may increase withdrawal symptoms between
doses. May be better tolerated in elderly and liver disease
patients.
rs for 24 hours followed by half the initial dose every 6 hours for 48 hours.
er depend on clinical response.
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for withdrawal has been observed in surgical patients
[57]. It is equally important to communicate to all pro-
viders when a known heavy drinker has passed the time
when initial manifestations of acute alcohol withdrawal
would be expected (within 2 to 3 days of the last drink).
Additional pre-discharge treatment considerations for
patients with an alcohol use disorder
Some research suggests hospitalization has the potential
to facilitate treatment for alcohol use disorders by in-
creasing recognition of the need to reduce drinking and
intent to do so [69-72]. Despite this, brief interventions
are unlikely to be effective at reducing drinking for hos-
pitalized patients with alcohol dependence [73], but fac-
tors including avoidance of heavily drinking friends and
engaging in alcohol treatment after hospitalization pre-
dict drinking reduction [71]. Thus referral for outpatient
treatment should be pursued and integrated into brief
intervention (i.e., SBIRT), but, even among research par-
ticipants, overall compliance with referral is modest
[73,74]. Brief intervention may be more effective in en-
hancing referral for women and younger adults [75].
Some evidence suggests that peer-involvement from vol-
unteer Alcoholics Anonymous members as a supple-
ment to brief intervention can increase treatment
initiation and abstinence following hospitalization [76].
Following hospital discharge, integrated outpatient treat-
ment (i.e., post-discharge care for alcoholism and medical
conditions with the same healthcare provider) may be ef-
fective under ideal conditions [77,78]. A related approach
involves a chronic disease management strategy in pri-
mary care with as-needed addiction specialist support,
which may improve the quality of outpatient care and fa-
cilitate recovery [79,80]. Thus it is reasonable to refer pa-
tients to this mode of primary care if it exists locally.
Other potential interventions prior to discharge must
be extrapolated from studies in treatment-seeking
alcohol-dependent populations or treatment strategies
implemented for other chronic medical and psychiatric
conditions. Taking advantage of findings in the alcohol-
ism pharmacotherapy field that show modest efficacy for
several medications coupled with brief counseling strat-
egies [81,82], an approach for alcohol dependent inpa-
tients might include brief interventions and initiation of
pharmacotherapy during the hospitalization. Several po-
tential medications are listed in Table 6, together with a
selection of their generally small effect sizes [83-87].
With the exception of disulfiram, medications for relapse
prevention target brain receptors thought to be involved
in relapse, including subsets of opioidergic, serotenergic,
glutamatergic, and dopaminergic receptors [88], and
complete abstinence may not be realized. As in the treat-
ment of other conditions such as hypertension, reducedpost-hospitalization drinking due to medication use may
be considered a successful albeit partial response, even if
the ultimate goal is abstinence. However, with the pos-
sible exception of transitional clinics following hospital
discharge, continuation of medication will mainly be in
the hands of ambulatory clinicians.
Unhealthy alcohol use and the joint commission
An impetus for a standardized approach to SBIRT for
unhealthy alcohol use, is the recent inclusion by JCAHO
of SBIRT as a quality care measure for hospitalized pa-
tients [5], and these recommendations have been sum-
marized [6]. In brief, JCAHO has recommended
screening for unhealthy use in all patients, brief inter-
vention for patients with unhealthy use, in-hospital
treatment or referral for alcohol use disorders, and con-
sideration of medications for alcohol dependence treat-
ment. Performance of these tasks would be measured by
self-reported outcomes through phone contact within 2
weeks of discharge.
This JCAHO initiative is grounded in the recognition
that unhealthy alcohol use and other drug use is a major
determinant of health in hospitalized patients, but has
been criticized due to insufficient evidence on the overall
effectiveness of SBIRT among general hospital inpatients
[6]. In that regard, the JCAHO quality initiative extends
beyond the evidence, but represents an attempt to inte-
grate research findings into medical care. This intent must
be applauded, and should be used as a springboard to fur-
ther develop methods that will improve patient outcomes
following an index hospitalization. The more severe nature
of unhealthy alcohol use in the hospital, the process of
SBIRT, and the intended outcomes should drive the re-
search agenda. Some thoughts in this regard are listed in
Table 7, which is not meant to be exhaustive. Research ef-
forts must be geared toward generic processes of care and
quality assessment, as the intent will be to improve patient
outcomes in settings where personnel with unique inter-
ests in this field are not always present.
Implementation barriers and facilitators
In general, major barriers to incorporation of evidence-
based care include organizational leadership, work cap-
acity, training, ongoing support, and others [89], and
SBIRT is no exception. A systematic review of qualitative
data from 47 studies [90] identified major SBIRT-
implementation barriers to be limited resources, train-
ing, support of management, and workload. Most results
were from primary-care-based studies, but, consistent
with these findings, critical components of implementing
and sustaining SBIRT at a rural hospital in Australia in-
cluded the support of hospital management and a dedi-
cated project worker [91]. Similar issues were also
identified for nursing-delivered SBIRT, with the addition
Table 6 Select Effects of Medications on Drinking Outcomes
Medication Drinking Outcome Effect estimate Source Factors Influencing Medication Choice
(95% CI or p-value)
Naltrexone Heavy drinking day
(≥ 60 grams alcohol)
Relative risk 0.83 Meta-analysis of 50 Avoid in patients with opioid abuse
or use; caution in liver disease and
advanced kidney disease(0.76-0.90) randomized controlled
trial (RCT’s) [87]
Acamprosate Any drinking Relative risk 0.86 Meta-analysis of 24 Avoid with advanced kidney disease
(e.g., creatinine clearance < 30 ml/min)
(0.81-0.91) RCT’s [86]
Disulfiram Any drinking Slight majority of trials
found improved
abstinence.
Review of 11 RCT’s [85] Avoid if alcohol-disulfiram reaction
medically dangerous; number of medical
conditions associated with accidental reaction;
avoidance of alcohol-containing products
Topiramate* % heavy drinking days 8.4% reduction Multicenter RCT [83] Caution with advanced liver or kidney disease;
risk for metabolic acidosis with predisposing
conditions; avoid abrupt discontinuation(3.1-13.8)
Ondansetron* Average number of
drinks on days alcohol
was consumed
If alcoholism onset before
age 25, 4.28 relative to
6.9 in placebo(p=0.004)
RCT [84] Not shown to be beneficial for later-onset
alcohol dependence; may prolong QT interval
*Not FDA-approved for treating alcohol dependence.
Makdissi and Stewart Addiction Science & Clinical Practice 2013, 8:11 Page 7 of 10
http://www.ascpjournal.org/content/8/1/11of concerns over limited interdisciplinary collaboration
about alcohol problems, compatibility with the acute
care nursing role, lack of privacy, and concerns about
patient attitudes [92]. This latter issue was also identified
in a previous hospital-based study on SBIRT [93]. Re-
garding training needs, SBIRT training programs have
been shown to increase provider comfort in assessing al-
cohol problems and have increased utilization of SBIRT
[94], and on-line instructional programs are available
to enhance dissemination (e.g., http://medicine.yale.
edu/sbirt/index.aspx; http://www.bu.edu/bniart/sbirt-in-Table 7 Potential research topics relevant to patient care and
Topic Potential research foci
Screening and assessment •Is there reason to use more than a
•Is there a better strategy than scre
•How should screening be integrat
•What is the role of newer alcohol
•What is the optimal assessment m
•What training will hospital-based c
alcohol use disorders?
•How do patients feel about assess
Treatment •What patients are most likely to re
•How can the beneficial effects of b
•How do we enhance the success
•Does pharmacotherapy for relapse
•What is the role for joint detection
•Can computerized support enhan
Measuring performance •What are the effects of brief interv
hospital readmission?
•What are the most pertinent patie
•What is the optimal method for ashealth-care/sbirt-educational-materials/sbirt-videos/). An
additional barrier is the lack of an unambiguous tool for
monitoring the quality of SBIRT, which ideally should
include assessment of core brief intervention compo-
nents rather than non-specific provider or patient report
of alcohol counseling [6,95]. Interestingly, implementa-
tion of a performance measure and electronic reminders
were each associated with an increase in the receipt of
brief intervention in outpatient VA settings [96], and this
type of strategy has the potential to enhance SBIRT per-
formance in the hospital [97].JCAHO quality measures
single heavy drinking day question to screen for unhealthy alcohol use?
ening all admissions?
ed with electronic work flows?
consumption biomarkers?
ethod in the hospital?
linicians require to enhance their skills and confidence in diagnosing
ment during hospitalization?
spond to brief intervention?
rief intervention on alcohol use be increased?
of referral?
prevention work in this population?
and treatment of other drug and mental health co-morbidities?
ce treatment?
ention on other outcomes such as progression of alcohol problems and
nt-centered outcomes?
sessing the quality of hospital-based SBIRT?
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Unhealthy alcohol use is common in hospitalized pa-
tients, with a high prevalence of severe alcohol problems
among those with unhealthy use. Detection should in-
clude the use of a validated screening instrument to de-
termine the presence of unhealthy use, and assessment
of alcohol-related consequences in patients with positive
screening results to categorize the severity of unhealthy
use. Based on current evidence, patients without an al-
cohol use disorder should receive a brief intervention to
target reduced drinking. Acute care issues for patients
with alcohol use disorders have been well described and
are standards of care. Additional research is needed to
guide discharge planning for inpatients with an alcohol
use disorder, but management should include referral to
outpatient addiction treatment if available, consideration
of medications to prevent a return to heavy drinking,
and explicit follow-up on alcohol use in the ambulatory
medical setting. JCAHO has advanced SBIRT for un-
healthy alcohol use as a quality measure, and barriers to
implementation are mainly generic factors rather than
specific to SBIRT. Continued research is needed across
the spectrum of unhealthy alcohol use to further demon-
strate the benefits of hospital-based SBIRT, refine the
process, and improve care for hospitalized patients.
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